Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Bone marrow aspirate versus platelet-rich fibrin for chronic plantar fasciitis

Official title: Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Plantar Fasciitis - A Double-Blind Randomized Clinical Trial

Run by Federal University of São Paulo · NCT07242729 · Data updated 2026-11-12

This compares injections of your own bone marrow aspirate versus platelet-rich fibrin to see which reduces heel pain and improves foot function in adults with chronic plantar fasciitis.

More Plantar Fasciitis trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment72 (estimated)
SponsorFederal University of São Paulo
Academic / other
Locations1 site (São Paulo)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2028
Registry record updatedNovember 21, 2025
Trial IDNCT07242729 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 years old with ultrasound-confirmed chronic plantar fasciitis for more than six months, baseline VAS ≥4, and persistent symptoms despite conservative care are the intended participants.

Probably not a fit

Patients with prior surgery on the affected limb, active local infection or ulceration, systemic inflammatory disease, poorly controlled metabolic disorders, or current use of systemic corticosteroids, immunosuppressants, or anticoagulants are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind trial compares ultrasound-guided injections of autologous bone marrow aspirate (harvested from the posterior iliac crest) versus platelet-rich fibrin into the plantar fascia of patients with chronic plantar fasciitis. Procedures are performed under sterile conditions with regional tibial nerve anesthesia and ultrasound guidance to precisely target the symptomatic area. Participants are followed for pain (Visual Analog Scale), foot function (Modified AOFAS), and ultrasonographic plantar fascia thickness at multiple time points up to 24 months. Safety and adverse events are recorded throughout the follow-up period.

Why it matters

Potential benefit: If successful, one of these orthobiologic injections could provide longer-lasting pain relief and better foot function for people who have not improved with standard conservative treatments.

How similar studies have gone: Smaller randomized trials and case series of platelet concentrates and bone marrow–derived products have shown promising reductions in pain and improved function, but head-to-head randomized comparisons between BMA and PRF are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 75 years.
* Clinical diagnosis of chronic plantar fasciitis for more than 6 months, confirmed by ultrasonography (increased plantar fascia thickness and hypoechogenicity).
* Persistent heel pain refractory to conventional conservative treatment (stretching, orthotics, physical therapy, or corticosteroid injections).
* Visual Analog Scale (VAS) pain score ≥ 4 at baseline.
* Ability and willingness to comply with study procedures and follow-up assessments.
* Signed informed consent.

Exclusion Criteria:

* Previous foot or ankle surgery on the affected limb.
* Acute trauma, infection, or ulceration in the region of the plantar fascia.
* Systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus, psoriatic arthritis).
* Metabolic or endocrine disorders interfering with healing (e.g., diabetes mellitus with poor glycemic control, thyroid disorders).
* Current use of systemic corticosteroids, immunosuppressants, or anticoagulants.
* Active neoplasia or hematologic disorders.
* Pregnancy or breastfeeding.
* Peripheral vascular disease or neuropathy affecting the lower limbs.
* Contraindications to local anesthesia or venipuncture.

Where it's running

  • Federal University of São Paulo - Hospital São Paulo
    São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.